This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Lg Household & Health Care Ltd.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Youn Jung Lee: Innovator in Osteoporosis and Menopausal Symptom Treatments
Introduction
Youn Jung Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of health care, particularly in the treatment of osteoporosis and menopausal symptoms. With a total of 2 patents, his work focuses on developing safe and effective compositions for alleviating these conditions.
Latest Patents
Youn Jung Lee's latest patents include a method for treating, preventing, or alleviating osteoporosis. This invention relates to a composition that is rapidly effective in preventing or alleviating menopausal symptoms. The composition can be used in conventional hormone replacement therapies (HRTs) and is noted for its lack of toxicity and minimal side effects. This makes it a safer alternative compared to traditional therapeutic agents for menopausal symptoms. Another patent focuses on a similar composition and method for treating menopausal symptoms, emphasizing its effectiveness and safety.
Career Highlights
Youn Jung Lee is currently associated with LG Household & Health Care Ltd. His work at this company has allowed him to innovate in the health care sector, particularly in developing solutions that address menopausal symptoms and osteoporosis.
Collaborations
He has collaborated with notable coworkers, including Ho Song Cho and Won Kyung Lee, contributing to the advancement of health care innovations.
Conclusion
Youn Jung Lee's contributions to the field of health care through his patents demonstrate his commitment to improving the quality of life for individuals experiencing menopausal symptoms and osteoporosis. His innovative approaches highlight the importance of safety and efficacy in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
